Affordable Access

deepdyve-link
Publisher Website

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes.

Authors
  • Abrahami, Devin1, 2
  • Douros, Antonios1, 3, 4
  • Yin, Hui1
  • Yu, Oriana H Y1, 5
  • Azoulay, Laurent6, 2, 7
  • 1 Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada. , (Canada)
  • 2 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. , (Canada)
  • 3 Department of Medicine, McGill University, Montreal, Canada. , (Canada)
  • 4 Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. , (Germany)
  • 5 Division of Endocrinology, Jewish General Hospital, Montreal, Canada. , (Canada)
  • 6 Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada [email protected] , (Canada)
  • 7 Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada. , (Canada)
Type
Published Article
Journal
Diabetes care
Publication Date
Sep 01, 2019
Volume
42
Issue
9
Identifiers
DOI: 10.2337/dc19-0849
PMID: 31296645
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times